SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-22-034990
Filing Date
2022-12-09
Accepted
2022-12-09 10:57:09
Documents
18

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 2449678
2 ex23-1.htm EX-23.1 7634
3 ex107.htm EX-FILING FEES 12153
4 formf-1a_001.jpg GRAPHIC 9359
5 formf-1a_002.jpg GRAPHIC 76342
6 formf-1a_003.jpg GRAPHIC 136696
7 formf-1a_004.jpg GRAPHIC 19681
8 formf-1a_005.jpg GRAPHIC 15729
9 formf-1a_006.jpg GRAPHIC 25106
10 formf-1a_007.jpg GRAPHIC 18514
11 formf-1a_008.jpg GRAPHIC 31534
12 formf-1a_009.jpg GRAPHIC 16605
13 formf-1a_010.jpg GRAPHIC 19347
14 formf-1a_011.jpg GRAPHIC 31331
15 formf-1a_012.jpg GRAPHIC 32897
16 formf-1a_013.jpg GRAPHIC 9361
17 ex23-1_001.jpg GRAPHIC 2105
18 ex23-1_002.jpg GRAPHIC 1561
  Complete submission text file 0001493152-22-034990.txt   3086536
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: F-1/A | Act: 33 | File No.: 333-268675 | Film No.: 221453977
SIC: 2836 Biological Products, (No Diagnostic Substances)